Precision Neuroscience, a brain-computer interface (BCI) company founded by former Neuralink co-founder Max Hodak, has announced the start of its first clinical study. The study will involve implanting a BCI device in the brains of five patients with severe spinal cord injuries.
The device, called the Precision Neural Interface, is designed to help patients with spinal cord injuries regain some control of their limbs. The device uses a combination of electrodes and software to record and stimulate neural activity.
The clinical study will test the safety and efficacy of the Precision Neural Interface. The study will also assess the device's ability to help patients with spinal cord injuries regain some control of their limbs.
Precision Neuroscience is one of several companies developing BCI devices. Other companies in this space include Neuralink, Kernel, and Synchron.
BCI devices have the potential to revolutionize the treatment of a variety of neurological disorders. However, more research is needed to assess the safety and efficacy of these devices.
The Precision Neural Interface clinical study is a significant step forward in the development of BCI devices. The results of the study will help to determine whether BCI devices can be used to help patients with spinal cord injuries regain some control of their limbs.
Here are some additional details about the Precision Neural Interface:
- The device is about the size of a quarter and is implanted in the brain using a minimally invasive procedure.
- The device has 96 electrodes that record neural activity from the brain.
- The device also has a stimulator that can be used to deliver electrical impulses to the brain.
- The device is connected to a computer that allows users to control it using their thoughts.
- Five patients with severe spinal cord injuries will be implanted with the Precision Neural Interface.
- The patients will be followed for one year to assess the safety and efficacy of the device.
- The patients will also be asked to complete a variety of tasks to assess their ability to control their limbs using the device.
